Cardinal Health, Inc. (CAH) Receives $74.49 Average Target Price from Analysts
Cardinal Health, Inc. (NYSE:CAH) has received an average recommendation of “Hold” from the nineteen analysts that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, twelve have assigned a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $74.49.
A number of research analysts have recently issued reports on CAH shares. Cowen Inc raised Cardinal Health to a “buy” rating and set a $74.00 price objective on the stock in a research note on Tuesday, October 10th. Needham & Company LLC restated a “hold” rating on shares of Cardinal Health in a research report on Thursday, October 12th. Robert W. Baird restated a “hold” rating and set a $73.00 price objective on shares of Cardinal Health in a research report on Sunday, September 17th. Jefferies Group LLC set a $77.00 price objective on shares of Cardinal Health and gave the stock a “hold” rating in a research report on Tuesday, August 29th. Finally, Mizuho set a $70.00 price objective on shares of Cardinal Health and gave the stock a “hold” rating in a research report on Tuesday, October 24th.
Shares of Cardinal Health (NYSE:CAH) traded down $0.60 on Thursday, hitting $56.37. The stock had a trading volume of 743,108 shares, compared to its average volume of 4,348,478. The firm has a market capitalization of $17,734.23, a price-to-earnings ratio of 10.70, a price-to-earnings-growth ratio of 1.63 and a beta of 0.88. The company has a debt-to-equity ratio of 1.35, a current ratio of 1.06 and a quick ratio of 0.52. Cardinal Health has a 52 week low of $54.66 and a 52 week high of $84.88.
Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Monday, November 6th. The company reported $1.09 EPS for the quarter, topping the Zacks’ consensus estimate of $1.00 by $0.09. Cardinal Health had a return on equity of 25.24% and a net margin of 0.84%. The firm had revenue of $32.64 billion during the quarter, compared to analyst estimates of $33.48 billion. During the same period last year, the company posted $1.24 EPS. The business’s quarterly revenue was up 1.9% compared to the same quarter last year. research analysts expect that Cardinal Health will post 4.97 earnings per share for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Tuesday, January 2nd will be issued a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a dividend yield of 3.28%. The ex-dividend date of this dividend is Friday, December 29th. Cardinal Health’s dividend payout ratio (DPR) is currently 53.78%.
Hedge funds have recently made changes to their positions in the stock. Security National Bank of Sioux City Iowa IA increased its position in shares of Cardinal Health by 0.3% during the second quarter. Security National Bank of Sioux City Iowa IA now owns 13,255 shares of the company’s stock valued at $1,033,000 after acquiring an additional 40 shares in the last quarter. Wetherby Asset Management Inc. increased its position in Cardinal Health by 0.5% during the 2nd quarter. Wetherby Asset Management Inc. now owns 8,392 shares of the company’s stock worth $654,000 after purchasing an additional 44 shares in the last quarter. Bessemer Group Inc. increased its position in Cardinal Health by 1.2% during the 2nd quarter. Bessemer Group Inc. now owns 4,238 shares of the company’s stock worth $330,000 after purchasing an additional 51 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its position in Cardinal Health by 0.3% during the 2nd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 23,468 shares of the company’s stock worth $1,829,000 after purchasing an additional 68 shares in the last quarter. Finally, Stratos Wealth Partners LTD. increased its position in Cardinal Health by 0.5% during the 2nd quarter. Stratos Wealth Partners LTD. now owns 14,509 shares of the company’s stock worth $1,131,000 after purchasing an additional 70 shares in the last quarter. Hedge funds and other institutional investors own 88.50% of the company’s stock.
About Cardinal Health
Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.
Receive News & Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.